{
    "status": "ok",
    "totalResults": 110,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "barchart.com",
            "title": "Will Boston Scientific Corporation (BSX) Continue Further upside?",
            "description": "Boston Scientific Corporation (BSX) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular segments. It offers devices to diagnose & treat different medica\u2026",
            "url": "https://biztoc.com/x/d47bd4c4f9ecfeee",
            "urlToImage": "https://c.biztoc.com/p/d47bd4c4f9ecfeee/s.webp",
            "publishedAt": "2023-11-28T23:10:52Z",
            "content": "Boston Scientific Corporation (BSX) develops, manufactures &amp; markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg &amp; Cardiovascu\u2026 [+174 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Coherent Market Insights Pvt. Ltd",
            "title": "Deep Brain Stimulation Devices Market to Hit $2,508.5 Million by 2030, Rising at 9.8% CAGR | Coherent Market Insights",
            "description": "Deep Brain Stimulation Devices Companies Analyzed are Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA. Deep Brain Stimulation Devices Companies Analyze\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/10/2778327/0/en/Deep-Brain-Stimulation-Devices-Market-to-Hit-2-508-5-Million-by-2030-Rising-at-9-8-CAGR-Coherent-Market-Insights.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/450ec960-647a-4b12-8885-a4afd6739e88",
            "publishedAt": "2023-11-10T13:35:00Z",
            "content": "Burlingame, Nov. 10, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global\u00a0deep brain stimulation device market is estimated to be valued at US$ 1,188.9 million in 2022 and is expect\u2026 [+10539 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Microbot Medical Inc.",
            "title": "Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities",
            "description": "The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase. The former Senior Medical Director for the Peripheral Interventions Divisio\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2784122/0/en/Microbot-Medical-Appoints-Seasoned-Medical-Expert-Dr-Juan-Diaz-Cartelle-as-its-New-Chief-Medical-Officer-in-Anticipation-of-Its-Clinical-Regulatory-and-Commercial-Activities.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/3a6663db-de72-4ae6-986e-78445cf43bb0",
            "publishedAt": "2023-11-21T14:12:00Z",
            "content": "BRAINTREE, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY\u00ae Endovascular Robotic Surgical System, today announced the appointment of\u2026 [+5950 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Needles Market Size To Worth USD13.39 Billion By 2032 | CAGR of 6.4%",
            "description": "The Needles Market Size was valued at USD 7.20 Billion in 2022 and the Worldwide Needles Market Size is expected to reach USD 13.39 Billion By 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered: Medtronic PLC,\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/15/2780854/0/en/Global-Needles-Market-Size-To-Worth-USD13-39-Billion-By-2032-CAGR-of-6-4.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-15T11:30:00Z",
            "content": "New York, United States, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Global Needles Market Size is expected to reach USD 13.39 Billion By 2032, at a CAGR of 6.4% during the forecast period 2022\u00a0to 2032.\r\nG\u2026 [+10812 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.",
            "description": "(marketscreener.com) \n\nRecent healthcare plan coverage of Intracept\u00ae system expands access to vertebrogenic pain treatment for tens of millions of patients\nMARLBOROUGH, Mass., Nov. 17, 2023 /PRNewswire/ --\u00a0Boston Scientific Corporation today announced the clo\u2026",
            "url": "https://www.marketscreener.com/quote/stock/BOSTON-SCIENTIFIC-CORPORA-11935/news/Boston-Scientific-Closes-Acquisition-of-Relievant-Medsystems-Inc-45385640/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-17T14:01:05Z",
            "content": "Recent healthcare plan coverage of Intracept\u00ae system expands access to vertebrogenic pain treatment for tens of millions of patients\r\nMARLBOROUGH, Mass., Nov. 17, 2023 /PRNewswire/ --\u00a0Boston Scientif\u2026 [+6032 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "InsightAce Analytic Pvt. LTd.",
            "title": "Peripheral Vascular Guidewires Market Exclusive Research Report with Forecast to 2031",
            "description": "Companies covered in this study are Terumo Corp, Abbott Laboratories, Boston Scientific Corp, Asahi Intecc Co Ltd, Cardinal Health, Cook Group Inc, Merit Medical Systems Inc, Medtronic plc, CONMED Corporation, Teleflex, Inc., B. Braun SE, Becton and Dickinson\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/30/2788413/0/en/Peripheral-Vascular-Guidewires-Market-Exclusive-Research-Report-with-Forecast-to-2031.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/0e88e2e9-67b2-4a38-aa13-e33c9d874fc5",
            "publishedAt": "2023-11-30T11:10:00Z",
            "content": "Jersey City, NJ, Nov. 30, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the \"Global Peripheral Vascular Guidewires Market- (By Type Of \u2026 [+8817 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific (NYSE:BSX) Hits New 1-Year High at $55.83",
            "description": "Shares of Boston Scientific Co. (NYSE:BSX \u2013 Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $55.83 and last traded at $55.55, with a volume of 502197 shares trading hands. The stock had previously clos\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/boston-scientific-nysebsx-hits-new-1-year-high-at-55-83/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T17:56:47Z",
            "content": "Shares of Boston Scientific Co. (NYSE:BSX \u2013 Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $55.83 and last traded at $55.55, with a volume o\u2026 [+5966 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific (NYSE:BSX) Shares Gap Up to $51.56",
            "description": "Shares of Boston Scientific Co. (NYSE:BSX \u2013 Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $51.56, but opened at $53.50. Boston Scientific shares last traded at $53.93, with a volume of 1,511,704 shares trad\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/boston-scientific-nysebsx-shares-gap-up-to-51-56/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T17:24:47Z",
            "content": "Shares of Boston Scientific Co. (NYSE:BSX \u2013 Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $51.56, but opened at $53.50. Boston Scientific shares l\u2026 [+6208 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Bronchoscopy Market Size To Worth USD 5.7 Billion by 2032 | CAGR of 6.8%",
            "description": "The Global Bronchoscopy Market Size was valued at USD 2.95 Billion in 2022 and the Worldwide Bronchoscopy Market Size is expected to reach USD 5.70 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2783957/0/en/Global-Bronchoscopy-Market-Size-To-Worth-USD-5-7-Billion-by-2032-CAGR-of-6-8.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-21T12:30:00Z",
            "content": "New York, United States, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The Global Bronchoscopy Market Size is To Grow from USD 2.95 Billion in 2022 to USD 5.70 Billion by 2032, at a Compound Annual Growth Rate (\u2026 [+10590 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Microcatheter Market Size To Worth USD 2.79 Billion By 2032 | CAGR of 3.7%",
            "description": "The Global Microcatheter Market Size was valued at USD 1.94 Billion in 2022 and the Worldwide Microcatheter Market Size is expected to reach USD 2.79 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Cover\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2784309/0/en/Global-Microcatheter-Market-Size-To-Worth-USD-2-79-Billion-By-2032-CAGR-of-3-7.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-21T17:30:00Z",
            "content": "New York, United States, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The Global Microcatheter Market Size is to grow from USD 1.94 Billion in 2022 to USD 2.79 Billion by 2032, at a Compound Annual Growth Rate \u2026 [+10930 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Savant Capital LLC Boosts Stake in Boston Scientific Co. (NYSE:BSX)",
            "description": "Savant Capital LLC grew its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 25.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,708 shares of the med\u2026",
            "url": "https://www.etfdailynews.com/2023/11/05/savant-capital-llc-boosts-stake-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-05T11:44:43Z",
            "content": "Savant Capital LLC grew its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 25.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Excha\u2026 [+6050 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific (NYSE:BSX) Hits New 52-Week High at $55.95",
            "description": "Boston Scientific Co. (NYSE:BSX \u2013 Get Free Report) hit a new 52-week high during trading on Thursday . The stock traded as high as $55.95 and last traded at $55.89, with a volume of 8345879 shares. The stock had previously closed at $55.44. Analysts Set New P\u2026",
            "url": "https://www.etfdailynews.com/2023/12/02/boston-scientific-nysebsx-hits-new-52-week-high-at-55-95/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-02T12:48:08Z",
            "content": "Boston Scientific Co. (NYSE:BSX \u2013 Get Free Report) hit a new 52-week high during trading on Thursday . The stock traded as high as $55.95 and last traded at $55.89, with a volume of 8345879 shares. T\u2026 [+5792 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "ProShare Advisors LLC Grows Stake in Boston Scientific Co. (NYSE:BSX)",
            "description": "ProShare Advisors LLC grew its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 4.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 230,429 shares \u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/proshare-advisors-llc-grows-stake-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T16:10:41Z",
            "content": "ProShare Advisors LLC grew its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 4.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange \u2026 [+6797 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Veritable L.P. Purchases 256 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "Veritable L.P. raised its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,722 shares of\u2026",
            "url": "https://www.etfdailynews.com/2023/11/17/veritable-l-p-purchases-256-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-17T15:38:44Z",
            "content": "Veritable L.P. raised its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.0% during the second quarter, according to the company in its most recent disclosure with the Secur\u2026 [+6657 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Profund Advisors LLC Increases Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "Profund Advisors LLC lifted its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 22,566 shares of the medical equip\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/profund-advisors-llc-increases-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T15:04:49Z",
            "content": "Profund Advisors LLC lifted its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.9% during the second quarter, according to the company in its most recent Form 13F filing wit\u2026 [+6350 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Natixis Has $4.80 Million Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "Natixis lowered its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 78.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,65\u2026",
            "url": "https://www.etfdailynews.com/2023/12/01/natixis-has-4-80-million-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-01T17:00:54Z",
            "content": "Natixis lowered its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 78.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Excha\u2026 [+6603 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Endoluminal Suturing Devices Market Size To Worth USD 285.58 Million By 2032 | CAGR of 11.6%",
            "description": "The Endoluminal suturing devices market was valued at USD 95.30 Million in 2022 and the Worldwide endoluminal suturing devices market is expected to reach USD 285.58 Million by 2032, according to a research report published by Spherical Insights & Consulting.\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2783761/0/en/Global-Endoluminal-Suturing-Devices-Market-Size-To-Worth-USD-285-58-Million-By-2032-CAGR-of-11-6.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-21T08:30:00Z",
            "content": "New York, United States, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The Global Endoluminal Suturing Devices Market Size is to grow from USD 95.30 Million in 2022 to USD 285.58 Million by 2032, at a Compound A\u2026 [+11191 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global ECG Cables and Lead Wires Market Size To Worth USD 3.94 Billion By 2032 | CAGR of 6.5%",
            "description": "The ECG Cables And Lead Wires Market was valued at USD 2.10 Billion in 2022.The Global ECG Cables And Lead Wires Market is expected to reach USD 3.94 Billion by 2032, According to a research report published by Spherical Insights & Consulting. Companies Cover\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/30/2788342/0/en/Global-ECG-Cables-and-Lead-Wires-Market-Size-To-Worth-USD-3-94-Billion-By-2032-CAGR-of-6-5.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-30T09:30:00Z",
            "content": "New York, United States , Nov. 30, 2023 (GLOBE NEWSWIRE) -- The Global ECG Cables and Lead Wires Market size is to grow from USD 2.10 Billion in 2022 to USD 3.94 Billion by 2032, at a Compound Annual\u2026 [+11039 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Gastrointestinal Stent Market Size To Worth USD 0.75 Billion By 2032 | CAGR of 4.8%",
            "description": "The Gastrointestinal Stent Market was valued at USD 0.47 Billion in 2022 The Global Gastrointestinal Stent Market is expected to reach USD 0.75 Billion by 2032, According to a research report published by Spherical Insights & Consulting. Companies Covered: Be\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/30/2788377/0/en/Global-Gastrointestinal-Stent-Market-Size-To-Worth-USD-0-75-Billion-By-2032-CAGR-of-4-8.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-30T10:30:00Z",
            "content": "New York, United States , Nov. 30, 2023 (GLOBE NEWSWIRE) -- The Global Gastrointestinal Stent Market Size is to grow from USD 0.47 Billion in 2022 to USD 0.75 Billion by 2032, at a Compound Annual Gr\u2026 [+11021 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "US Bancorp DE Has $23.37 Million Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "US Bancorp DE cut its holdings in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.3% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 432,096 shares of the medical equipment provider\u2019s stock after selling 14,951 shares \u2026",
            "url": "https://www.etfdailynews.com/2023/11/18/us-bancorp-de-has-23-37-million-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-18T17:06:43Z",
            "content": "US Bancorp DE cut its holdings in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.3% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 432,096 shares of the med\u2026 [+6158 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "OPTIMAS CAPITAL Ltd Acquires New Shares in Boston Scientific Co. (NYSE:BSX)",
            "description": "OPTIMAS CAPITAL Ltd acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 53,526 shares of the medi\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/optimas-capital-ltd-acquires-new-shares-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T17:38:42Z",
            "content": "OPTIMAS CAPITAL Ltd acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange C\u2026 [+6191 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Cary Street Partners Investment Advisory LLC Decreases Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "Cary Street Partners Investment Advisory LLC cut its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.8% in the 2nd quarter, HoldingsChannel reports. The firm owned 18,144 shares of the medical equipment provider\u2019s stock after selling\u2026",
            "url": "https://www.etfdailynews.com/2023/11/19/cary-street-partners-investment-advisory-llc-decreases-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-19T14:08:12Z",
            "content": "Cary Street Partners Investment Advisory LLC cut its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.8% in the 2nd quarter, HoldingsChannel reports. The firm owned 18,144 sh\u2026 [+6322 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Kestra Advisory Services LLC Trims Stock Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "Kestra Advisory Services LLC trimmed its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 18.4% during the 2nd quarter, Holdings Channel reports. The fund owned 123,983 shares of the medical equipment provider\u2019s stock after selling 27,9\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/kestra-advisory-services-llc-trims-stock-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T18:10:54Z",
            "content": "Kestra Advisory Services LLC trimmed its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 18.4% during the 2nd quarter, Holdings Channel reports. The fund owned 123,983 shares \u2026 [+6883 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Shares Bought by O Shaughnessy Asset Management LLC",
            "description": "O Shaughnessy Asset Management LLC grew its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 24.3% in the second quarter, HoldingsChannel reports. The fund owned 127,118 shares of the medical equipment provider\u2019s stock after buying an a\u2026",
            "url": "https://www.etfdailynews.com/2023/11/25/boston-scientific-co-nysebsx-shares-bought-by-o-shaughnessy-asset-management-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-25T13:54:50Z",
            "content": "O Shaughnessy Asset Management LLC grew its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 24.3% in the second quarter, HoldingsChannel reports. The fund owned 127,118 shares\u2026 [+7065 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "iSAM Funds UK Ltd Makes New Investment in Boston Scientific Co. (NYSE:BSX)",
            "description": "iSAM Funds UK Ltd acquired a new stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 32,804 shares of the medica\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/isam-funds-uk-ltd-makes-new-investment-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T16:56:43Z",
            "content": "iSAM Funds UK Ltd acquired a new stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchan\u2026 [+6677 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "HAP Trading LLC Has $730,000 Stock Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "HAP Trading LLC decreased its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 22.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,495 shares of the medical \u2026",
            "url": "https://www.etfdailynews.com/2023/11/23/hap-trading-llc-has-730000-stock-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-23T17:20:49Z",
            "content": "HAP Trading LLC decreased its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 22.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Excha\u2026 [+6372 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Summit Financial LLC Sells 403 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "Summit Financial LLC decreased its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,473 shares of th\u2026",
            "url": "https://www.etfdailynews.com/2023/11/28/summit-financial-llc-sells-403-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-28T16:56:56Z",
            "content": "Summit Financial LLC decreased its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and E\u2026 [+6271 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Banque Cantonale Vaudoise Purchases 1,315 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "Banque Cantonale Vaudoise increased its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,802 s\u2026",
            "url": "https://www.etfdailynews.com/2023/11/14/banque-cantonale-vaudoise-purchases-1315-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-14T13:28:53Z",
            "content": "Banque Cantonale Vaudoise increased its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.3% in the second quarter, according to the company in its most recent filing with the\u2026 [+6190 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Northern Trust Corp Has $722.57 Million Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "Northern Trust Corp decreased its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/northern-trust-corp-has-722-57-million-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T16:48:46Z",
            "content": "Northern Trust Corp decreased its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Ex\u2026 [+6196 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Mirae Asset Global Investments Co. Ltd. Sells 176,117 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "Mirae Asset Global Investments Co. Ltd. reduced its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 10.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,466,10\u2026",
            "url": "https://www.etfdailynews.com/2023/11/18/mirae-asset-global-investments-co-ltd-sells-176117-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-18T14:56:47Z",
            "content": "Mirae Asset Global Investments Co. Ltd. reduced its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 10.7% in the second quarter, according to its most recent Form 13F filing with the Secur\u2026 [+6216 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "TD Asset Management Inc Raises Stake in Boston Scientific Co. (NYSE:BSX)",
            "description": "TD Asset Management Inc grew its stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 16.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,142,309 shares of the medi\u2026",
            "url": "https://www.etfdailynews.com/2023/11/15/td-asset-management-inc-raises-stake-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-15T14:04:44Z",
            "content": "TD Asset Management Inc grew its stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 16.7% in the second quarter, according to its most recent disclosure with the Securities and Exch\u2026 [+6247 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Stock Position Trimmed by Sirios Capital Management L P",
            "description": "Sirios Capital Management L P cut its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 5.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 432,\u2026",
            "url": "https://www.etfdailynews.com/2023/12/01/boston-scientific-co-nysebsx-stock-position-trimmed-by-sirios-capital-management-l-p/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-01T18:26:51Z",
            "content": "Sirios Capital Management L P cut its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 5.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the S\u2026 [+6279 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Mount Lucas Management LP Invests $2.64 Million in Boston Scientific Co. (NYSE:BSX)",
            "description": "Mount Lucas Management LP bought a new position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 48,868 shares of the medical equipment pro\u2026",
            "url": "https://www.etfdailynews.com/2023/12/04/mount-lucas-management-lp-invests-2-64-million-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-04T17:16:42Z",
            "content": "Mount Lucas Management LP bought a new position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutiona\u2026 [+6223 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Rhumbline Advisers Has $158.13 Million Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "Rhumbline Advisers grew its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 0.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,923,519 shares of the \u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/rhumbline-advisers-has-158-13-million-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T14:52:48Z",
            "content": "Rhumbline Advisers grew its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 0.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and \u2026 [+6296 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific (NYSE:BSX) Price Target Raised to $64.00 at Canaccord Genuity Group",
            "description": "Boston Scientific (NYSE:BSX \u2013 Get Free Report) had its target price hoisted by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a report issued on Monday, Benzinga reports. The brokerage currently has a \u201cbuy\u201d rating on the medical equipme\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/boston-scientific-nysebsx-price-target-raised-to-64-00-at-canaccord-genuity-group/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T19:22:44Z",
            "content": "Boston Scientific (NYSE:BSX \u2013 Get Free Report) had its target price hoisted by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a report issued on Monday, Benzinga reports. The b\u2026 [+6097 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Bleakley Financial Group LLC Raises Stock Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "Bleakley Financial Group LLC boosted its holdings in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 261,810 shares of the medical equipment provider\u2019s sto\u2026",
            "url": "https://www.etfdailynews.com/2023/12/04/bleakley-financial-group-llc-raises-stock-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-04T19:22:45Z",
            "content": "Bleakley Financial Group LLC boosted its holdings in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund \u2026 [+6281 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Meitav Investment House Ltd. Takes Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "Meitav Investment House Ltd. purchased a new stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 26,400 shares \u2026",
            "url": "https://www.etfdailynews.com/2023/11/17/meitav-investment-house-ltd-takes-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-17T16:58:41Z",
            "content": "Meitav Investment House Ltd. purchased a new stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities &amp; Exchange\u2026 [+6162 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Ilmarinen Mutual Pension Insurance Co Purchases Shares of 160,000 Boston Scientific Co. (NYSE:BSX)",
            "description": "Ilmarinen Mutual Pension Insurance Co acquired a new position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/ilmarinen-mutual-pension-insurance-co-purchases-shares-of-160000-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T15:52:45Z",
            "content": "Ilmarinen Mutual Pension Insurance Co acquired a new position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) in the 2nd quarter, according to its most recent disclosure with the Securiti\u2026 [+6248 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Stock Holdings Lifted by Fund Management at Engine No. 1 LLC",
            "description": "Fund Management at Engine No. 1 LLC raised its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 7.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional inve\u2026",
            "url": "https://www.etfdailynews.com/2023/12/01/boston-scientific-co-nysebsx-stock-holdings-lifted-by-fund-management-at-engine-no-1-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-01T15:56:48Z",
            "content": "Fund Management at Engine No. 1 LLC raised its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 7.8% during the second quarter, according to its most recent Form 13F filing with the Secu\u2026 [+6134 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "The Manufacturers Life Insurance Company Lowers Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "The Manufacturers Life Insurance Company cut its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 0.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor o\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/the-manufacturers-life-insurance-company-lowers-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T15:02:54Z",
            "content": "The Manufacturers Life Insurance Company cut its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 0.2% during the 2nd quarter, according to its most recent 13F filing with the Securities\u2026 [+7031 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Shares Sold by Metropolitan Life Insurance Co NY",
            "description": "Metropolitan Life Insurance Co NY cut its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,6\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/boston-scientific-co-nysebsx-shares-sold-by-metropolitan-life-insurance-co-ny/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T13:43:21Z",
            "content": "Metropolitan Life Insurance Co NY cut its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exch\u2026 [+6783 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Brown Brothers Harriman & Co. Decreases Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "Brown Brothers Harriman & Co. cut its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 34.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,911 share\u2026",
            "url": "https://www.etfdailynews.com/2023/11/07/brown-brothers-harriman-co-decreases-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-07T11:57:06Z",
            "content": "Brown Brothers Harriman &amp; Co. cut its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 34.4% during the second quarter, according to its most recent 13F filing with the Securities and E\u2026 [+6767 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Winslow Capital Management LLC Invests $237.97 Million in Boston Scientific Co. (NYSE:BSX)",
            "description": "Winslow Capital Management LLC acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 4,3\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/winslow-capital-management-llc-invests-237-97-million-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T20:06:45Z",
            "content": "Winslow Capital Management LLC acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to the company in its most recent filing with the Sec\u2026 [+6951 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "ExodusPoint Capital Management LP Purchases 201,709 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "ExodusPoint Capital Management LP boosted its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 125.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional inv\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/exoduspoint-capital-management-lp-purchases-201709-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T15:58:57Z",
            "content": "ExodusPoint Capital Management LP boosted its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 125.5% in the second quarter, according to the company in its most recent disclosure with t\u2026 [+6503 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "O Neil Global Advisors Inc. Acquires 8,462 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "O Neil Global Advisors Inc. boosted its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 169.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,462 shares of the\u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/o-neil-global-advisors-inc-acquires-8462-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T17:04:53Z",
            "content": "O Neil Global Advisors Inc. boosted its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 169.2% during the 2nd quarter, according to its most recent filing with the Securities \u2026 [+6553 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Shares Acquired by Bank Pictet & Cie Europe AG",
            "description": "Bank Pictet & Cie Europe AG raised its stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 10.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,350\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/boston-scientific-co-nysebsx-shares-acquired-by-bank-pictet-cie-europe-ag/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T14:24:51Z",
            "content": "Bank Pictet &amp; Cie Europe AG raised its stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 10.7% during the 2nd quarter, according to the company in its most recent 13F filing wi\u2026 [+6522 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Gyroscope Capital Management Group LLC Makes New Investment in Boston Scientific Co. (NYSE:BSX)",
            "description": "Gyroscope Capital Management Group LLC bought a new stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,0\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/gyroscope-capital-management-group-llc-makes-new-investment-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T15:50:41Z",
            "content": "Gyroscope Capital Management Group LLC bought a new stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to the company in its most recent disclosure wi\u2026 [+6669 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Bradley Foster & Sargent Inc. CT Cuts Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "Bradley Foster & Sargent Inc. CT trimmed its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 21.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm \u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/bradley-foster-sargent-inc-ct-cuts-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T18:26:42Z",
            "content": "Bradley Foster &amp; Sargent Inc. CT trimmed its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 21.8% during the 2nd quarter, according to the company in its most recent Form\u2026 [+6558 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "B. Metzler seel. Sohn & Co. AG Sells 7,177 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "B. Metzler seel. Sohn & Co. AG reduced its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1\u2026",
            "url": "https://www.etfdailynews.com/2023/11/25/b-metzler-seel-sohn-co-ag-sells-7177-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-25T17:20:42Z",
            "content": "B. Metzler seel. Sohn &amp; Co. AG reduced its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.9% during the second quarter, according to its most recent 13F filing with the Securities a\u2026 [+6402 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Landscape Capital Management L.L.C. Invests $884,000 in Boston Scientific Co. (NYSE:BSX)",
            "description": "Landscape Capital Management L.L.C. bought a new position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor \u2026",
            "url": "https://www.etfdailynews.com/2023/11/25/landscape-capital-management-l-l-c-invests-884000-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-25T14:46:47Z",
            "content": "Landscape Capital Management L.L.C. bought a new position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Sec\u2026 [+6955 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Pinnacle Wealth Planning Services Inc. Cuts Stake in Boston Scientific Co. (NYSE:BSX)",
            "description": "Pinnacle Wealth Planning Services Inc. lowered its stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 5.1% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 8,734 shares of the medical equipment provide\u2026",
            "url": "https://www.etfdailynews.com/2023/11/05/pinnacle-wealth-planning-services-inc-cuts-stake-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-05T13:48:44Z",
            "content": "Pinnacle Wealth Planning Services Inc. lowered its stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 5.1% during the 2nd quarter, according to its most recent filing with the SEC. \u2026 [+6886 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Stock Position Reduced by Rhenman & Partners Asset Management AB",
            "description": "Rhenman & Partners Asset Management AB cut its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm own\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/boston-scientific-co-nysebsx-stock-position-reduced-by-rhenman-partners-asset-management-ab/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T20:16:41Z",
            "content": "Rhenman &amp; Partners Asset Management AB cut its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 3.3% during the second quarter, according to its most recent Form 13F filing\u2026 [+7349 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Smithfield Trust Co Has $427,000 Stock Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "Smithfield Trust Co lifted its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 12.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,875 shares of the medical equipmen\u2026",
            "url": "https://www.etfdailynews.com/2023/11/10/smithfield-trust-co-has-427000-stock-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-10T17:38:48Z",
            "content": "Smithfield Trust Co lifted its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 12.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Com\u2026 [+6710 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Shares Sold by Altfest L J & Co. Inc.",
            "description": "Altfest L J & Co. Inc. cut its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,090 shares o\u2026",
            "url": "https://www.etfdailynews.com/2023/11/14/boston-scientific-co-nysebsx-shares-sold-by-altfest-l-j-co-inc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-14T16:38:47Z",
            "content": "Altfest L J &amp; Co. Inc. cut its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Excha\u2026 [+7104 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Shares Purchased by Fisher Asset Management LLC",
            "description": "Fisher Asset Management LLC raised its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,840,973 shares o\u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/boston-scientific-co-nysebsx-shares-purchased-by-fisher-asset-management-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T16:00:45Z",
            "content": "Fisher Asset Management LLC raised its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.4% during the 2nd quarter, according to the company in its most recent filing with the Securitie\u2026 [+7185 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Boston Scientific Co. (NYSE:BSX) Stock Holdings Raised by Sei Investments Co.",
            "description": "Sei Investments Co. raised its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 14.0% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 4,854,263 shares of the medical equipment provider\u2019s stock after purchasing an\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/boston-scientific-co-nysebsx-stock-holdings-raised-by-sei-investments-co/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T19:02:50Z",
            "content": "Sei Investments Co. raised its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 14.0% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 4,854,263 shares o\u2026 [+6865 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Employees Retirement System of Texas Purchases 32,000 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "Employees Retirement System of Texas increased its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 4.5% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 74\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/employees-retirement-system-of-texas-purchases-32000-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T19:40:42Z",
            "content": "Employees Retirement System of Texas increased its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 4.5% in the 2nd quarter, according to the company in its most recent filing \u2026 [+7369 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "AXQ Capital LP Acquires New Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "AXQ Capital LP bought a new position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 8,690 shares of t\u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/axq-capital-lp-acquires-new-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T17:48:47Z",
            "content": "AXQ Capital LP bought a new position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securitie\u2026 [+6387 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Diamond Hill Capital Management Inc. Decreases Stock Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "Diamond Hill Capital Management Inc. lessened its holdings in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 728,\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/diamond-hill-capital-management-inc-decreases-stock-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T16:30:41Z",
            "content": "Diamond Hill Capital Management Inc. lessened its holdings in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.8% during the second quarter, according to the company in its most recent filing with\u2026 [+6546 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Russell Investments Group Ltd. Has $36.55 Million Stock Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "Russell Investments Group Ltd. reduced its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 23.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The ins\u2026",
            "url": "https://www.etfdailynews.com/2023/11/19/russell-investments-group-ltd-has-36-55-million-stock-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-19T15:22:41Z",
            "content": "Russell Investments Group Ltd. reduced its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 23.6% in the 2nd quarter, according to the company in its most recent Form 13F filin\u2026 [+6816 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $92.86 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1,240.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,716,792 shares of t\u2026",
            "url": "https://www.etfdailynews.com/2023/11/30/british-columbia-investment-management-corp-has-92-86-million-stock-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-30T17:54:42Z",
            "content": "BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1,240.2% during the second quarter, according to the company in its most recent 1\u2026 [+6374 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Shepherd Financial Partners LLC Sells 793 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "Shepherd Financial Partners LLC cut its holdings in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,470 shares of the me\u2026",
            "url": "https://www.etfdailynews.com/2023/11/30/shepherd-financial-partners-llc-sells-793-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-30T17:06:48Z",
            "content": "Shepherd Financial Partners LLC cut its holdings in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and\u2026 [+6308 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Mitsubishi UFJ Trust & Banking Corp Sells 352 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "Mitsubishi UFJ Trust & Banking Corp decreased its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 0.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional invest\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/mitsubishi-ufj-trust-banking-corp-sells-352-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T13:44:42Z",
            "content": "Mitsubishi UFJ Trust &amp; Banking Corp decreased its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 0.0% during the second quarter, according to its most recent filing with \u2026 [+6425 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Principal Financial Group Inc. Reduces Stake in Boston Scientific Co. (NYSE:BSX)",
            "description": "Principal Financial Group Inc. lessened its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,830,7\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/principal-financial-group-inc-reduces-stake-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T12:16:44Z",
            "content": "Principal Financial Group Inc. lessened its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.4% in the 2nd quarter, according to its most recent Form 13F filing with the Secu\u2026 [+7116 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Aveo Capital Partners LLC Cuts Stock Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "Aveo Capital Partners LLC lessened its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,602 shares of the me\u2026",
            "url": "https://www.etfdailynews.com/2023/11/10/aveo-capital-partners-llc-cuts-stock-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-10T15:58:58Z",
            "content": "Aveo Capital Partners LLC lessened its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 2.7% during the 2nd quarter, according to its most recent filing with the Securities and\u2026 [+6355 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Schroder Investment Management Group Buys 475,071 Shares of Boston Scientific Co. (NYSE:BSX)",
            "description": "Schroder Investment Management Group grew its stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 22.7% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,567,550 shares of the med\u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/schroder-investment-management-group-buys-475071-shares-of-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T14:44:59Z",
            "content": "Schroder Investment Management Group grew its stake in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 22.7% during the second quarter, according to the company in its most recent disclos\u2026 [+7049 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Polar Capital Holdings Plc Decreases Holdings in Boston Scientific Co. (NYSE:BSX)",
            "description": "Polar Capital Holdings Plc lowered its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 33.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor own\u2026",
            "url": "https://www.etfdailynews.com/2023/12/03/polar-capital-holdings-plc-decreases-holdings-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-03T16:56:44Z",
            "content": "Polar Capital Holdings Plc lowered its stake in Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 33.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securi\u2026 [+6812 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "WINTON GROUP Ltd Boosts Stock Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "WINTON GROUP Ltd boosted its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 294.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 119,720 shares of the medical\u2026",
            "url": "https://www.etfdailynews.com/2023/12/04/winton-group-ltd-boosts-stock-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-04T16:00:41Z",
            "content": "WINTON GROUP Ltd boosted its holdings in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 294.2% during the 2nd quarter, according to its most recent 13F filing with the Securities &amp; E\u2026 [+6314 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities",
            "description": "(marketscreener.com) The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase.BRAINTREE, Mass., Nov. 21, 2023 -- Microbot Medical Inc\u2026",
            "url": "https://www.marketscreener.com/quote/stock/MICROBOT-MEDICAL-INC-45615636/news/Microbot-Medical-Appoints-Seasoned-Medical-Expert-Dr-Juan-Diaz-Cartelle-as-its-New-Chief-Medical-O-45408580/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-21T14:13:01Z",
            "content": "The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase.\r\nBRAINTREE, Mas\u2026 [+6142 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "State Board of Administration of Florida Retirement System Has $86.37 Million Position in Boston Scientific Co. (NYSE:BSX)",
            "description": "State Board of Administration of Florida Retirement System lessened its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission\u2026",
            "url": "https://www.etfdailynews.com/2023/11/25/state-board-of-administration-of-florida-retirement-system-has-86-37-million-position-in-boston-scientific-co-nysebsx/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/logo_Boston_Scientific.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-25T16:11:07Z",
            "content": "State Board of Administration of Florida Retirement System lessened its position in shares of Boston Scientific Co. (NYSE:BSX \u2013 Free Report) by 1.5% during the 2nd quarter, according to its most rece\u2026 [+7135 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Electrosurgery Market Size To Worth USD 10.81 Billion By 2032 | CAGR of 5.8%",
            "description": "The Global Electrosurgery Market was valued at USD 6.15 Billion in 2022 and the Worldwide Electrosurgery Market is expected to reach USD 10.81 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered: Med\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/27/2786019/0/en/Global-Electrosurgery-Market-Size-To-Worth-USD-10-81-Billion-By-2032-CAGR-of-5-8.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-27T12:00:00Z",
            "content": "New York, United States, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The Global Electrosurgery Market size is to grow from USD 6.15 Billion in 2022 to USD 10.81 Billion by 2032, at a Compound Annual Growth Rat\u2026 [+10025 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "LifeLens Technologies, Inc.",
            "title": "LifeLens Technologies Expands Executive Leadership Team and Board of Directors",
            "description": "PHILADELPHIA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeLens Technologies, Inc. (LifeLens), a medical technology company that provides real-time physiological monitoring, today announced the appointment of three industry veterans to the following positions on its\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/08/2776108/0/en/LifeLens-Technologies-Expands-Executive-Leadership-Team-and-Board-of-Directors.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/bd1d5d25-6311-4af3-a985-83fb0b1ccecb",
            "publishedAt": "2023-11-08T12:30:00Z",
            "content": "PHILADELPHIA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeLens Technologies, Inc. (LifeLens), a medical technology company that provides real-time physiological monitoring, today announced the appointment \u2026 [+4059 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Fortune Business Insights",
            "title": "Interventional Oncology Market Size to Surpass USD 3.45 billion by 2030, exhibiting a CAGR of 7.9%",
            "description": "As per the report by Fortune Business Insights, the global Interventional Oncology Market size is projected to reach USD 3.45 billion in 2030, at a CAGR of 7.9% during the forecast period, 2023-2030 As per the report by Fortune Business Insights, the global I\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/27/2786045/0/en/Interventional-Oncology-Market-Size-to-Surpass-USD-3-45-billion-by-2030-exhibiting-a-CAGR-of-7-9.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/05408ba1-26b1-4fdd-8f48-1af4df373348",
            "publishedAt": "2023-11-27T12:18:00Z",
            "content": "Pune, India, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The interventional oncology market\r\n size is projected to grow from USD 2.02 billion in 2023 to USD 3.45 billion by 2030, exhibiting a CAGR of 7.9% duri\u2026 [+7006 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Stent Market to Grow with Innovative Advancements and Growing Geriatric Population, Forecasted at 6.46% CAGR through 2028",
            "description": "Dublin, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The \"Global Stent Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028\" report has been added to ResearchAndMarkets.com's offering.",
            "url": "https://www.globenewswire.com/news-release/2023/11/15/2781180/28124/en/Stent-Market-to-Grow-with-Innovative-Advancements-and-Growing-Geriatric-Population-Forecasted-at-6-46-CAGR-through-2028.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-15T15:08:00Z",
            "content": "Dublin, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The \"Global Stent Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028\" report has been added to ResearchAndMarkets.com's offering.\r\nT\u2026 [+3897 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "MarketsandMarkets Research Pvt. Ltd.",
            "title": "Dermatology Devices Market is Expected to Reach $11.3 billion | MarketsandMarkets.",
            "description": "Chicago, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Dermatology Devices market in terms of revenue was estimated to be worth $6.2 billion in 2022 and is poised to reach $11.3 billion by 2027, growing at a CAGR of 12.7% from 2022 to 2027 according to a latest report pu\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/13/2778931/0/en/Dermatology-Devices-Market-is-Expected-to-Reach-11-3-billion-MarketsandMarkets.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/afcc5182-4ae0-43a8-a965-4351d590b7ed",
            "publishedAt": "2023-11-13T12:30:00Z",
            "content": "Chicago, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Dermatology Devices market in terms of revenue was estimated to be worth $6.2 billion in 2022 and is poised to reach $11.3 billion by 2027, growing at a CAG\u2026 [+8863 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "CounterPunch"
            },
            "author": "Ron Jacobs",
            "title": "Washington and Israel: A Murderous Relationship",
            "description": "Israel is a colonial-settler project. Like the Americas\u2014especially the east coast of the United States which was originally settled by various religious and cultural outcasts\u2014Israel was established as a homeland for the Jews, probably the most outcast of any \u2026",
            "url": "https://www.counterpunch.org/2023/11/17/washington-and-israel-a-murderous-relationship/",
            "urlToImage": "https://www.counterpunch.org/wp-content/uploads/2023/11/curioso-photography-xYrTdhysQY0-unsplash-scaled.jpg",
            "publishedAt": "2023-11-17T06:58:04Z",
            "content": "Image by Curioso Photography.\r\nIsrael is a colonial-settler project. Like the Americasespecially the east coast of the United States which was originally settled by various religious and cultural out\u2026 [+15586 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Emergen Research",
            "title": "Needles Market Size Worth USD 15.27 Billion in 2032 | Emergen Research",
            "description": "Increasing number of hospitals and clinic in emerging countries and rising prevalence of chronic illnesses, such as cancer and diabetes, are key factors driving needles market revenue growth. Increasing number of hospitals and clinic in emerging countries and\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/22/2784705/0/en/Needles-Market-Size-Worth-USD-15-27-Billion-in-2032-Emergen-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/8825ef83-644c-4c64-a208-863167237797",
            "publishedAt": "2023-11-22T12:17:00Z",
            "content": "Vancouver, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The global needles market\r\n size was USD 6.91 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.7% during the forecast period. Key dri\u2026 [+12017 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "CORE SCIENTIFIC : AND ITS AFFILIATED DEBTORS - Form 8-K",
            "description": "(marketscreener.com) , each a\"Specified Transaction\"). For the avoidance of doubt, the Tranche 1 Initial Exercise Price shall not be adjusted in the event New Common Interests are issued as a result of the exercise of the Tranche 2 Warrants.\n \n \n \n \n \n \n \n \n \u2026",
            "url": "https://www.marketscreener.com/quote/stock/CORE-SCIENTIFIC-INC-132124750/news/CORE-SCIENTIFIC-AND-ITS-AFFILIATED-DEBTORS-Form-8-K-45366365/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-15T22:32:08Z",
            "content": "CORE SCIENTIFIC, INC. AND ITS AFFILIATED DEBTORS\r\nTHIS PLAN (AS MAY BE AMENDED) WILL BE SUBMITTED FOR APPROVAL BUT HAS NOT BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT A SOLICITATION OF ACCEPTA\u2026 [+481568 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "CORE SCIENTIFIC : AND ITS AFFILIATED DEBTORS - Form 8-K",
            "description": "(marketscreener.com) , each a \"Specified Transaction\"). For the avoidance of doubt, the Tranche 1 Initial Exercise Price shall not be adjusted in the event New Common Interests are issued as a result of the exercise of the Tranche 2 Warrants.\n \n \n \n \n \n \n \n \n\u2026",
            "url": "https://www.marketscreener.com/quote/stock/CORE-SCIENTIFIC-INC-132124750/news/CORE-SCIENTIFIC-AND-ITS-AFFILIATED-DEBTORS-Form-8-K-45384865/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-17T12:55:05Z",
            "content": "CORE SCIENTIFIC, INC. AND ITS AFFILIATED DEBTORS\r\n<table><tr><td></td></tr><tr><td>WEIL, GOTSHAL &amp; MANGES LLP\r\nAlfredo R. P\u00e9rez (15776275)\r\nClifford W. Carlson (24090024)\r\n700 Louisiana Street, S\u2026 [+505492 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "CORE SCIENTIFIC : AND ITS AFFILIATED DEBTORS - Form 8-K",
            "description": "(marketscreener.com) , each a\"Specified Transaction\"). For the avoidance of doubt, the Tranche 1 Initial Exercise Price shall not be adjusted in the event New Common Interests are issued as a result of the exercise of the Tranche 2 Warrants.\n \n \n \n \n \n \n \n \n \u2026",
            "url": "https://www.marketscreener.com/quote/stock/CORE-SCIENTIFIC-INC-132124750/news/CORE-SCIENTIFIC-AND-ITS-AFFILIATED-DEBTORS-Form-8-K-45315780/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-13T22:01:04Z",
            "content": "CORE SCIENTIFIC, INC. AND ITS AFFILIATED DEBTORS\r\n2\r\nTHIS PLAN (AS MAY BE AMENDED) WILL BE SUBMITTED FOR APPROVAL BUT HAS NOT BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT A SOLICITATION OF ACCE\u2026 [+481022 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Emergen Research",
            "title": "Occlusion Devices Market Size Worth USD 5,588.20 Million by 2032 | Emergen Research",
            "description": "The rising incidence of cardiovascular diseases is one of the significant factors influencing the occlusion devices market growth The rising incidence of cardiovascular diseases is one of the significant factors influencing the occlusion devices market growth",
            "url": "https://www.globenewswire.com/news-release/2023/11/13/2779311/0/en/Occlusion-Devices-Market-Size-Worth-USD-5-588-20-Million-by-2032-Emergen-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/8825ef83-644c-4c64-a208-863167237797",
            "publishedAt": "2023-11-13T17:30:00Z",
            "content": "Vancouver, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The global occlusion devices market\r\n is projected to be worth USD 5,588.20 Million by 2032, according to a current analysis by Emergen Research. The occl\u2026 [+8419 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Kymanox",
            "title": "Kymanox Named as Winner of 2023 Triangle Business Journal Fast 50 Award",
            "description": "Leading global life science professional services organization is committed to continued growth because patients deserve better. Leading global life science professional services organization is committed to continued growth because patients deserve better.",
            "url": "https://www.globenewswire.com/news-release/2023/11/14/2780450/0/en/Kymanox-Named-as-Winner-of-2023-Triangle-Business-Journal-Fast-50-Award.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/33a9af84-ffc8-4378-8219-61f763fbf0b4",
            "publishedAt": "2023-11-14T19:48:00Z",
            "content": "Research Triangle Park, North Carolina, USA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Kymanox Corporation\r\n (Kymanox), a professional services company exclusively serving the Life Science industry, announce\u2026 [+2578 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Emergen Research",
            "title": "Nerve Repair and Regeneration Market Size Worth USD 14.21 Billion in 2032 | Emergen Research",
            "description": "Rising prevalence of neurological disorders is a key factor driving nerve repair & regeneration market revenue growth Rising prevalence of neurological disorders is a key factor driving nerve repair & regeneration market revenue growth",
            "url": "https://www.globenewswire.com/news-release/2023/11/15/2781333/0/en/Nerve-Repair-and-Regeneration-Market-Size-Worth-USD-14-21-Billion-in-2032-Emergen-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/8825ef83-644c-4c64-a208-863167237797",
            "publishedAt": "2023-11-15T17:55:00Z",
            "content": "Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The global Nerve Repair and Regeneration Market\r\n will be worth USD\u00a014.21 Billion by 2032, according to a current analysis by Emergen Research. The growth\u2026 [+8250 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "Global Neuromodulation Market Size & Share to Surpass $14.8 Billion by 2030 | Vantage Market Research",
            "description": "WASHINGTON, Nov. 22, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Neuromodulation Market is estimated to be valued at USD 14.8 Billion by 2030 at an exponential growth of 12.2% in the next seven years.",
            "url": "https://www.globenewswire.com/news-release/2023/11/22/2784936/0/en/Global-Neuromodulation-Market-Size-Share-to-Surpass-14-8-Billion-by-2030-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-11-22T16:15:00Z",
            "content": "WASHINGTON, Nov. 22, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Neuromodulation Market is estimated to be valued at USD 14.8 Billion by 2030 at an exponential growth of\u2026 [+12165 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Interventional Radiology Systems Strategic Analysis Report 2023: Market to Reach $39.3 Billion by 2030 from $22.8 Billion in 2022 - AI Holds Tremendous Potential",
            "description": "Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The \"Interventional Radiology Systems - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.Global Interventional Radiology Systems Market to Reach $39.3 Billion by 2030The glo\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2774803/28124/en/Global-Interventional-Radiology-Systems-Strategic-Analysis-Report-2023-Market-to-Reach-39-3-Billion-by-2030-from-22-8-Billion-in-2022-AI-Holds-Tremendous-Potential.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-07T10:48:00Z",
            "content": "Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The \"Interventional Radiology Systems - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.\r\nGlobal Interventional \u2026 [+7082 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED",
            "title": "IoT Medical Devices Market projected to surpass USD 313.63 Billion by 2030, growing at a CAGR of 33.5% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study.",
            "description": "The Global IoT Medical Devices Market was valued USD 41.5 Billion in 2023 and projected to reach USD 313.63 Billion by 2030, growing at a CAGR of 33.5% during the forecast period of 2023-2030. The Global IoT Medical Devices Market was valued USD 41.5 Billion \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/15/2780839/0/en/IoT-Medical-Devices-Market-projected-to-surpass-USD-313-63-Billion-by-2030-growing-at-a-CAGR-of-33-5-during-the-forecast-period-of-2023-2030-pronounced-by-MarketDigits-in-its-recen.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/2960b872-d623-4363-9973-e881f17bf42f",
            "publishedAt": "2023-11-15T11:00:00Z",
            "content": "Richmond, Nov. 15, 2023 (GLOBE NEWSWIRE) -- According to a research report \"IoT medical devices market\r\n, by Product Type (Vital Signs Monitoring Devices, Imaging Systems, Respiratory Devices, Implan\u2026 [+11230 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Male Urinary Incontinence Market Report 2023-2030: Combination of Digital Health Solutions and Telemedicine to Improve Access to Diagnosis and Treatment",
            "description": "Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The \"Male Urinary Incontinence Market Size, Share & Trends Analysis Report By Product (Non-absorbents, Absorbents), By Incontinence Type, By Usage, By Distribution Channel, By End-use, By Region, And Segment Forecasts\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/24/2785615/28124/en/Global-Male-Urinary-Incontinence-Market-Report-2023-2030-Combination-of-Digital-Health-Solutions-and-Telemedicine-to-Improve-Access-to-Diagnosis-and-Treatment.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-24T14:28:00Z",
            "content": "Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The \"Male Urinary Incontinence Market Size, Share &amp; Trends Analysis Report By Product (Non-absorbents, Absorbents), By Incontinence Type, By Usage, By Di\u2026 [+9529 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Cardiology IT Workflow Solutions Market Report 2023-2030 - Rise of IT in Healthcare Provides the Foundation for Adoption",
            "description": "Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The \"Cardiology IT Workflow Solutions - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.Global Cardiology IT Workflow Solutions Market to Reach $1.8 Billion by 2030The glob\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/30/2788286/28124/en/Global-Cardiology-IT-Workflow-Solutions-Market-Report-2023-2030-Rise-of-IT-in-Healthcare-Provides-the-Foundation-for-Adoption.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-30T08:08:00Z",
            "content": "Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The \"Cardiology IT Workflow Solutions - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.\r\nGlobal Cardiology IT W\u2026 [+5495 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Kynexis",
            "title": "Kynexis Launched to Advance Precision Therapeutics for Brain Diseases",
            "description": "- Lead Candidate KYN-5356, a First-In-Class Small Molecule KAT-II Inhibitor, Advancing Toward the Clinic for Cognitive Impairment Associated With Schizophrenia",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2774771/0/en/Kynexis-Launched-to-Advance-Precision-Therapeutics-for-Brain-Diseases.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/cc6eebb7-91d8-415e-8e68-54f1c4bf5ef4",
            "publishedAt": "2023-11-07T10:00:00Z",
            "content": "- Lead Candidate KYN-5356, a First-In-Class Small Molecule KAT-II Inhibitor, Advancing Toward the Clinic for Cognitive Impairment Associated With Schizophrenia\r\n- 57 Million Series A Led by Forbion\r\n\u2026 [+5637 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Rationalstat LLC",
            "title": "Revolutionizing Skin Care: Dermatology Lasers Market Witnesses Exponential Growth Amidst Focus on Beauty, Health, and Well-being \u2013 Says RationalStat",
            "description": "The global dermatology market is expected to reach US$ 2,548.1 million by 2030, with an annual growth rate of more than 7.3%. The global dermatology market is expected to reach US$ 2,548.1 million by 2030, with an annual growth rate of more than 7.3%.",
            "url": "https://www.globenewswire.com/news-release/2023/11/17/2782461/0/en/Revolutionizing-Skin-Care-Dermatology-Lasers-Market-Witnesses-Exponential-Growth-Amidst-Focus-on-Beauty-Health-and-Well-being-Says-RationalStat.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ced67b94-5d6b-4532-b365-e1f1f26f8f16",
            "publishedAt": "2023-11-17T10:54:00Z",
            "content": "Wilmington, Delaware, Nov. 17, 2023 (GLOBE NEWSWIRE) -- According to RationalStat\r\ns\r\n most recent industry analysis, the Global \r\nDermatology Lasers\r\n Market\r\n value is estimated at US$ 1,553.7 mill\u2026 [+10592 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Rationalstat LLC",
            "title": "Spine Surgery Medical Equipment Market to Reach US$ 15.9 Billion by 2030, Driven by Growing Demand for Minimally Invasive Procedures and Advanced Technologies",
            "description": "The global spine surgery medical equipment market is expected to reach US$ 15.9 billion by 2030, with an annual growth rate of more than 4.5%, says RationalStat The global spine surgery medical equipment market is expected to reach US$ 15.9 billion by 2030, w\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2784125/0/en/Spine-Surgery-Medical-Equipment-Market-to-Reach-US-15-9-Billion-by-2030-Driven-by-Growing-Demand-for-Minimally-Invasive-Procedures-and-Advanced-Technologies.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ced67b94-5d6b-4532-b365-e1f1f26f8f16",
            "publishedAt": "2023-11-21T14:15:00Z",
            "content": "Wilmington, Nov. 21, 2023 (GLOBE NEWSWIRE) -- According to RationalStat\r\ns\r\n recent market report, the Global \r\nSpine Surgery Medical Equipment\r\n Market\r\n value is estimated at US$ 11.7 billion in 20\u2026 [+10259 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Future Market Insights Global and Consulting Pvt. Ltd.",
            "title": "Microcatheter Market Size to Hit US$ 3 billion, globally by 2033 | Future Market Insights, Inc.",
            "description": "The Rising Rate of Chronic Disorders is Driving the Market for Microcatheters. Global microcatheter market driven by initiatives, partnerships, and applications, but facses regulatory challenges and surgical limitations. The Rising Rate of Chronic Disorders i\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/06/2773781/0/en/Microcatheter-Market-Size-to-Hit-US-3-billion-globally-by-2033-Future-Market-Insights-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa",
            "publishedAt": "2023-11-06T09:30:00Z",
            "content": "NEWARK, Del, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The global microcatheter market is estimated to be US$ 2 billion in 2022 and is projected to reach US$ 2.1 billion by 2023. The market is expected to gr\u2026 [+9142 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED",
            "title": "Neurostimulation Market projected to reach USD 9.9 Billion by 2030, growing at a CAGR of 9.3% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study",
            "description": "The Global Neurostimulation Market was valued USD 5.3 Billion in 2023 and projected to reach USD 9.9 Billion by 2030, growing at a CAGR of 9.3% during the forecast period of 2023-2030. The Global Neurostimulation Market was valued USD 5.3 Billion in 2023 and \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2784174/0/en/Neurostimulation-Market-projected-to-reach-USD-9-9-Billion-by-2030-growing-at-a-CAGR-of-9-3-during-the-forecast-period-of-2023-2030-pronounced-by-MarketDigits-in-its-recent-study.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/2960b872-d623-4363-9973-e881f17bf42f",
            "publishedAt": "2023-11-21T15:00:00Z",
            "content": "Richmond, Nov. 21, 2023 (GLOBE NEWSWIRE) -- According to a research report \"Neurostimulation Market\r\n, byType (Internal Neurostimulation (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve\u2026 [+11190 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Emergen Research",
            "title": "Spinal Implants and Surgery Devices Market Size Worth USD 18.41 Billion in 2032 | Emergen Research",
            "description": "The growing geriatric population is one of the significant factors influencing the Spinal Implants and Surgery Devices Market growth The growing geriatric population is one of the significant factors influencing the Spinal Implants and Surgery Devices Market \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/16/2782007/0/en/Spinal-Implants-and-Surgery-Devices-Market-Size-Worth-USD-18-41-Billion-in-2032-Emergen-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/8825ef83-644c-4c64-a208-863167237797",
            "publishedAt": "2023-11-16T15:15:00Z",
            "content": "Vancouver, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The global spinal implants and surgery devices market\r\n is projected to be worth USD 18.41 Billion by 2032, according to a current analysis by Emergen Res\u2026 [+8877 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "TAVR Embolic Protection Market to Reach $405.4 Million, Globally, by 2032 at 14% CAGR: Allied Market Research",
            "description": "Reduction in mortality rate using TAVR embolic protection devices, technological advancements in TAVR embolic protection devices, and rise in adoption of minimally invasive procedures drive the growth of the global TAVR embolic protection market. PORTLAND, Or\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/tavr-embolic-protection-market-to-reach-405-4-million-globally-by-2032-at-14-cagr-allied-market-research-301984302.html",
            "urlToImage": "https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg?p=facebook",
            "publishedAt": "2023-11-10T15:05:00Z",
            "content": "Reduction in mortality rate using TAVR embolic protection devices, technological advancements in TAVR embolic protection devices, and rise in adoption of minimally invasive procedures drive the growt\u2026 [+8002 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Future Market Insights Global and Consulting Pvt. Ltd.",
            "title": "Sports Medicine Market Soars with a 6.0% CAGR, expected to Hit US$ 2,062.7 Million by 2033 | Future Market Insights Inc.",
            "description": "Standalone Analyzers Segment is expected to constitute a share of 55.9% in the Sports Medicine Market in 2023, FMI Report. The use of robotics in knee surgeries has significantly reduced the risk of complications and improved patient outcomes but the rising i\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2783958/0/en/Sports-Medicine-Market-Soars-with-a-6-0-CAGR-expected-to-Hit-US-2-062-7-Million-by-2033-Future-Market-Insights-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa",
            "publishedAt": "2023-11-21T12:30:00Z",
            "content": "NEWARK, Del, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global sports medicine market is anticipated to reach a valuation of US$ 1,157.0 million in 2023, driven by a focus on mental health in sports. The \u2026 [+9947 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Acoustic Wave Sensors Business Report 2023: Market to Reach $1.3 Billion by 2030 - Ongoing Proliferation of Industry 4.0 & IIoT Set to Alter Market Dynamics",
            "description": "Dublin, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The \"Acoustic Wave Sensors - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.Global Acoustic Wave Sensors Market to Reach $1.3 Billion by 2030The global market for Acoustic\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/12/01/2789367/28124/en/Global-Acoustic-Wave-Sensors-Business-Report-2023-Market-to-Reach-1-3-Billion-by-2030-Ongoing-Proliferation-of-Industry-4-0-IIoT-Set-to-Alter-Market-Dynamics.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-12-01T14:48:00Z",
            "content": "Dublin, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The \"Acoustic Wave Sensors - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.\r\nGlobal Acoustic Wave Sensors Mark\u2026 [+6243 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Transparency Market Research",
            "title": "Atherectomy Systems Market to Hit USD 1.1 billion by 2031 | Says Transparency Market Research Inc.",
            "description": "Rise in prevalence of peripheral and coronary artery diseases is expected to propel the global atherectomy systems industry growth during the forecast period. Rise in prevalence of peripheral and coronary artery diseases is expected to propel the global ather\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2783762/32656/en/Atherectomy-Systems-Market-to-Hit-USD-1-1-billion-by-2031-Says-Transparency-Market-Research-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/27b21b27-620b-4cae-8360-605a9662092b",
            "publishedAt": "2023-11-21T08:30:00Z",
            "content": "Wilmington, Delaware, United States, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global atherectomy systems market stood at US$ 650 million in 2022, and the global market\u2026 [+7251 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "FACT.MR",
            "title": "Bioabsorbable Implant Market Expected To Reach US$ 836.5 Million by 2034 : Fact.MR Analysis",
            "description": "Material Science Innovations Offering Advanced Bioabsorbable Implants with Enhanced Properties Material Science Innovations Offering Advanced Bioabsorbable Implants with Enhanced Properties",
            "url": "https://www.globenewswire.com/news-release/2023/11/19/2782846/0/en/Bioabsorbable-Implant-Market-Expected-To-Reach-US-836-5-Million-by-2034-Fact-MR-Analysis.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/f482b854-04d1-4f4e-9237-f7c7c6823e10",
            "publishedAt": "2023-11-19T21:00:00Z",
            "content": "Rockville , Nov. 19, 2023 (GLOBE NEWSWIRE) -- As per the latest industry analysis by Fact.MR, a market research and competitive intelligence provider, the global\u00a0bioabsorbable implant market is estim\u2026 [+6884 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Medical Laser Systems Market Analysis Report, 2022 and 2023-2026: New Product Launches, Use of AI and Increasing Cosmetic Treatments Shaping Market Expansion",
            "description": "Dublin, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The \"Global Medical Laser Systems Market (by Product Type, Application, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)\" report has been added to ResearchAndMarkets.com's offerin\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2783822/28124/en/Global-Medical-Laser-Systems-Market-Analysis-Report-2022-and-2023-2026-New-Product-Launches-Use-of-AI-and-Increasing-Cosmetic-Treatments-Shaping-Market-Expansion.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-21T10:43:00Z",
            "content": "Dublin, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The \"Global Medical Laser Systems Market (by Product Type, Application, End User, &amp; Region): Insights &amp; Forecast with Potential Impact of COVID-19 (2\u2026 [+9205 chars]"
        }
    ]
}